549 results on '"Biessels GJ"'
Search Results
2. Perforating artery flow velocity and pulsatility in patients with carotid occlusive disease. A 7 tesla MRI study
- Author
-
Onkenhout, L.P., Arts, Tine, Ferro, D., Oudeman, E.A., van Osch, M.J.P., Zwanenburg, J.J.M., Hendrikse, J., Kappelle, L.J., and Biessels, GJ.
- Published
- 2022
- Full Text
- View/download PDF
3. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)
- Author
-
Biessels, GJ, Bril, V, Calcutt, NA, Cameron, NE, Cotter, MA, Dobrowsky, R, Feldman, EL, Fernyhough, P, Jakobsen, J, Malik, RA, Mizisin, AP, Oates, PJ, Obrosova, IG, Pop‐Busui, R, Russell, JW, Sima, AA, Stevens, MJ, Schmidt, RE, Tesfaye, S, Veves, A, Vinik, AI, Wright, DE, Yagihashi, S, Yorek, MA, Ziegler, D, and Zochodne, DW
- Subjects
Biomedical and Clinical Sciences ,Neurosciences ,Diabetes ,Neurodegenerative ,Chronic Pain ,Peripheral Neuropathy ,Pain Research ,Metabolic and endocrine ,Good Health and Well Being ,Animals ,Behavior ,Animal ,Biomedical Research ,Consensus ,Diabetic Neuropathies ,Disease Models ,Animal ,Humans ,Neural Conduction ,Peripheral Nerves ,Phenotype ,diabetes ,diabetic neuropathy ,neuropathy ,peripheral neuropathy ,Neurology & Neurosurgery ,Clinical sciences - Abstract
NIDDK, JDRF, and the Diabetic Neuropathy Study Group of EASD sponsored a meeting to explore the current status of animal models of diabetic peripheral neuropathy. The goal of the workshop was to develop a set of consensus criteria for the phenotyping of rodent models of diabetic neuropathy. The discussion was divided into five areas: (1) status of commonly used rodent models of diabetes, (2) nerve structure, (3) electrophysiological assessments of nerve function, (4) behavioral assessments of nerve function, and (5) the role of biomarkers in disease phenotyping. Participants discussed the current understanding of each area, gold standards (if applicable) for assessments of function, improvements of existing techniques, and utility of known and exploratory biomarkers. The research opportunities in each area were outlined, providing a possible roadmap for future studies. The meeting concluded with a discussion on the merits and limitations of a unified approach to phenotyping rodent models of diabetic neuropathy and a consensus formed on the definition of the minimum criteria required for establishing the presence of the disease. A neuropathy phenotype in rodents was defined as the presence of statistically different values between diabetic and control animals in 2 of 3 assessments (nocifensive behavior, nerve conduction velocities, or nerve structure). The participants propose that this framework would allow different research groups to compare and share data, with an emphasis on data targeted toward the therapeutic efficacy of drug interventions.
- Published
- 2014
4. The Impact of Strategic White Matter Hyperintensity Lesion Location on Language.
- Author
-
Hilal, S, Biesbroek, JM, Vrooman, H, Chong, E, Kuijf, HJ, Venketasubramanian, N, Cheng, C-Y, Wong, TY, Biessels, GJ, Chen, C, Hilal, S, Biesbroek, JM, Vrooman, H, Chong, E, Kuijf, HJ, Venketasubramanian, N, Cheng, C-Y, Wong, TY, Biessels, GJ, and Chen, C
- Abstract
OBJECTIVE: The impact of white matter hyperintensities (WMH) on language possibly depends on lesion location through disturbance of strategic white matter tracts. We examined the impact of WMH location on language in elderly Asians. DESIGN: Cross-sectional. SETTING: Population-based. PARTICIPANTS: Eight-hundred nineteen residents of Singapore, ages (≥65 years). MEASUREMENTS: Clinical, cognitive and 3T magnetic resonance imaging assessments were performed on all participants. Language was assessed using the Modified Boston Naming Test (MBNT) and Verbal Fluency (VF). Hypothesis-free region-of-interest-based (ROI) analyses based on major white matter tracts were used to determine the association between WMH location and language. Conditional dependencies between the regional WMH volumes and language were examined using Bayesian-network analysis. RESULTS: ROI-based analyses showed that WMH located within the anterior thalamic radiation (mean difference: -0.12, 95% confidence interval [CI]: -0.22; -0.02, p = 0.019) and uncinate fasciculus (mean difference: -0.09, 95% CI: -0.18; -0.01, p = 0.022) in the left hemisphere were significantly associated with worse VF but did not survive multiple testing. Conversely, WMH volume in the left cingulum of cingulate gyrus was significantly associated with MBNT performance (mean difference: -0.09, 95% CI: -0.17; -0.02, p = 0.016). Bayesian-network analyses confirmed the left cingulum of cingulate gyrus as a direct determinant of MBNT performance. CONCLUSION: Our findings identify the left cingulum of cingulate gyrus as a strategic white matter tract for MBNT, suggesting that language - is sensitive to subcortical ischemic damage. Future studies on the role of sporadic ischemic lesions and vascular cognitive impairment should not only focus on total WMH volume but should also take WMH lesion location into account when addressing language.
- Published
- 2021
5. CARDIAC BIOMARKERS AND LEFT VENTRICULAR FUNCTION IN RELATION TO VASCULAR BRAIN INJURY AND COGNITIVE FUNCTIONING
- Author
-
Amier, Raquel, primary, Marcks, N., additional, Leeuwis, A., additional, Nijveldt, Robin, additional, Biessels, GJ, additional, Kappelle, LJ, additional, van Oostenbrugge, R., additional, van der Geest, RJ, additional, Bots, Michiel, additional, Greving, J., additional, Niessen, Wiro, additional, de Bresser, J., additional, Mooijaart, S., additional, van der Flier, W., additional, Rocca, Hans-Peter Brunner-La, additional, and van Rossum, Albert, additional
- Published
- 2021
- Full Text
- View/download PDF
6. Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future
- Author
-
Mok, VCT, Pendlebury, S, Wong, A, Alladi, S, Au, L, Bath, PM, Biessels, GJ, Chen, C, Cordonnier, C, Dichgans, M, Dominguez, J, Gorelick, PB, Kim, SY, Kwok, T, Greenberg, SM, Jia, J, Kalaria, R, Kivipelto, M, Naegandran, K, Lam, LCW, Lam, BYK, Lee, ATC, Markus, HS, O'Brien, J, Pai, MC, Pantoni, L, Sachdev, P, Skoog, I, Smith, EE, Srikanth, V, Suh, GH, Wardlaw, J, Ko, H, Black, SE, Scheltens, P, Mok, VCT, Pendlebury, S, Wong, A, Alladi, S, Au, L, Bath, PM, Biessels, GJ, Chen, C, Cordonnier, C, Dichgans, M, Dominguez, J, Gorelick, PB, Kim, SY, Kwok, T, Greenberg, SM, Jia, J, Kalaria, R, Kivipelto, M, Naegandran, K, Lam, LCW, Lam, BYK, Lee, ATC, Markus, HS, O'Brien, J, Pai, MC, Pantoni, L, Sachdev, P, Skoog, I, Smith, EE, Srikanth, V, Suh, GH, Wardlaw, J, Ko, H, Black, SE, and Scheltens, P
- Abstract
We have provided an overview on the profound impact of COVID-19 upon older people with Alzheimer's disease and other dementias and the challenges encountered in our management of dementia in different health-care settings, including hospital, out-patient, care homes, and the community during the COVID-19 pandemic. We have also proposed a conceptual framework and practical suggestions for health-care providers in tackling these challenges, which can also apply to the care of older people in general, with or without other neurological diseases, such as stroke or parkinsonism. We believe this review will provide strategic directions and set standards for health-care leaders in dementia, including governmental bodies around the world in coordinating emergency response plans for protecting and caring for older people with dementia amid the COIVD-19 outbreak, which is likely to continue at varying severity in different regions around the world in the medium term.
- Published
- 2020
7. Diabetes-specific dementia risk score (DSDRS) predicts cognitive performance in patients with type 2 diabetes at high cardio-renal risk
- Author
-
Verhagen, C, Janssen, J, Exalto, LG, van den Berg, Esther, Johansen, OE, Biessels, GJ, Verhagen, C, Janssen, J, Exalto, LG, van den Berg, Esther, Johansen, OE, and Biessels, GJ
- Published
- 2020
8. Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion
- Author
-
Ferro, DA, Mutsaerts, HJ, Hilal, Saima, Kuijf, HJ, Petersen, ET, Petr, J, van Veluw, SJ, Venketasubramanian, N, Yeow, TB, Biessels, GJ, Chen, C, Ferro, DA, Mutsaerts, HJ, Hilal, Saima, Kuijf, HJ, Petersen, ET, Petr, J, van Veluw, SJ, Venketasubramanian, N, Yeow, TB, Biessels, GJ, and Chen, C
- Published
- 2020
9. Cortical Microinfarcts and White Matter Connectivity in Memory Clinic Patients
- Author
-
Ferro, DA, Heinen, R, de Brito Robalo, BM, Kuijf, HJ, Biessels, GJ, Reijmer, YD, and Utrecht Vascular Cognitive Impairment (VCI) Study group
- Subjects
microinfarcts ,Diffusion tensor imaging ,Neurology ,cerebral small vessel disease ,Clinical Neurology ,White matter connectivity ,Vascular cognitive impairment - Abstract
Background and purpose: Cerebral microinfarcts (CMIs) are associated with cognitive impairment and dementia. CMIs might affect cognitive performance through disruption of cerebral networks. We investigated in memory clinic patients whether cortical CMIs are clustered in specific brain regions and if presence of cortical CMIs is associated with reduced white matter (WM) connectivity in tracts projecting to these regions. Methods: 164 memory clinic patients with vascular brain injury with a mean age of 72 ± 11 years (54% male) were included. All underwent 3 tesla MRI, including a diffusion MRI and cognitive testing. Cortical CMIs were rated according to established criteria and their spatial location was marked. Diffusion imaging-based tractography was used to reconstruct WM connections and voxel based analysis (VBA) to assess integrity of WM directly below the cortex. WM connectivity and integrity were compared between patients with and without cortical CMIs for the whole brain and regions with a high CMI burden. Results: 30 patients (18%) had at least 1 cortical CMI [range 1–46]. More than 70% of the cortical CMIs were located in the superior frontal, middle frontal, and pre- and postcentral brain regions (covering 16% of the cortical surface). In these high CMI burden regions, presence of cortical CMIs was not associated with WM connectivity after correction for conventional neuroimaging markers of vascular injury. WM connectivity in the whole brain and WM voxels directly underneath the cortical surface did not differ between patients with and without cortical CMIs. Conclusion: Cortical CMIs displayed a strong local clustering in highly interconnected frontal, pre- and postcentral brain regions. Nevertheless, WM connections projecting to these regions were not disproportionally impaired in patients with compared to patients without cortical CMIs. Alternative mechanisms, such as focal disturbances in cortical structure and functioning, may better explain CMI associated cognitive impairment.
- Published
- 2019
10. Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion
- Author
-
Ferro, D.A., Mutsaerts, H., Hilal, S., Kuijf, HJ, Petersen, E.T., Petr, J., van Veluw, S.J., Venketasubramanian, N. (Narayanaswamy), Yeow, T.B., Biessels, GJ, Chen, C., Ferro, D.A., Mutsaerts, H., Hilal, S., Kuijf, HJ, Petersen, E.T., Petr, J., van Veluw, S.J., Venketasubramanian, N. (Narayanaswamy), Yeow, T.B., Biessels, GJ, and Chen, C.
- Abstract
Cerebral cortical microinfarcts (CMIs) are small ischemic lesions associated with cognitive impairment and dementia. CMIs are frequently observed in cortical watershed areas suggesting that hypoperfusion contributes to their development. We investigated if presence of CMIs was related to a decrease in cerebral perfusion, globally or specifically in cortex surrounding CMIs. In 181 memory clinic patients (mean age 72 9 years, 51% male), CMI presence was rated on 3-T magnetic resonance imaging (MRI). Cerebral perfusion was assessed from cortical gray matter of the anterior circulation using pseudo-continuous arterial spin labeling parameters cerebral blood flow (CBF) (perfusion in mL blood/ 100 g tissue/min) and spatial coefficient of variation (CoV) (reflecting arterial transit time (ATT)). Patients with CMIs had a 12% lower CBF (beta ¼ .20) and 22% higher spatial CoV (beta ¼ .20) (both p <.05) without a specific regional pattern on voxel-based CBF analysis. CBF in a 2 cm region-of-interest around the CMIs did not differ from CBF in a reference zone in the contralateral hemisphere. These findings show that CMIs in memory clinic patients are primarily related to global reductions in cerebral perfusion, thus shed
- Published
- 2019
- Full Text
- View/download PDF
11. Nonfocal transient neurological attacks are related to cognitive impairment in patients with heart failure
- Author
-
Oudeman, E.A., Greving, J.P. (Jacoba), Hooghiemstra, A.M., Brunner-La Rocca, H.P., Biessels, GJ, Kappelle, L.J. (Jaap), Daemen, M.J.A.P. (Mat), Buchem, M.A. (Mark) van, van der Geest, RJ, van Osch, MJP, Roos, A.N. (Anja), Flier, W.M. (Wiesje) van der, Rossum, A.C. (Albert) van, la Rocca, HPB, Ikram, M.A. (Arfan), Koudstaal, P.J. (Peter), Niessen, W.J. (Wiro), van Oostenbrugge, R, Bots, M.L. (Michiel), Oudeman, E.A., Greving, J.P. (Jacoba), Hooghiemstra, A.M., Brunner-La Rocca, H.P., Biessels, GJ, Kappelle, L.J. (Jaap), Daemen, M.J.A.P. (Mat), Buchem, M.A. (Mark) van, van der Geest, RJ, van Osch, MJP, Roos, A.N. (Anja), Flier, W.M. (Wiesje) van der, Rossum, A.C. (Albert) van, la Rocca, HPB, Ikram, M.A. (Arfan), Koudstaal, P.J. (Peter), Niessen, W.J. (Wiro), van Oostenbrugge, R, and Bots, M.L. (Michiel)
- Abstract
Introduction Nonfocal transient neurological attacks (TNAs) are associated with an increased risk of future dementia, but it is unclear whether TNAs are also associated with concurrent cognitive impairment. We hypothesized that recent TNAs are related to worse cognitive functioning. We tested our hypothesis in patients with heart failure, as these patients are at risk of cerebral hypoperfusion, which might play a role in the etiology of TNAs. Methods We performed neuropsychological testing in all patients with heart failure enrolled in the Heart Brain Connection study. We assessed global cognition, attention-psychomotor speed, executive functioning, memory and language. All patients were interviewed with a standardized questionnaire on the occurrence of TNAs in the preceding 6 months. We studied associations between TNAs and cognitive functioning with linear and logistic regression analyses, adjusted for age, sex and education. We performed additional analyses in patients without previous stroke or TIA and in patients without brain infarction on MRI. Results Thirty-seven (23%) of 158 patients (mean age 70 years, 67% men) experienced one or more TNAs. Patients with a recent TNA were more likely to be impaired on≥1 cognitive domains than patients without TNAs [41% vs. 18%, adjusted odds ratio 4.6, 95% confdence interval (CI) 1.8–11.8]. Patients with TNAs performed worse than patients without TNAs on global cognition (mean diference in z scores −0.36, 95% CI −0.54 to −0.18), and on the cognitive domains attentionpsychomotor speed (mean diference −0.40, 95% CI −0.66 to −0.14), memory (mean diference −0.57, 95% CI −0.98 to −0.15) and language (mean diference −0.47, 95% CI −0.79 to −0.16). These associations were independent of cardiac output and volume of white matter hyperintensities. Subgroup analyses in patients without previous stroke or TIA or brain infarction on MRI (n=78) yielded comparable results, with the exception of the cognitive domain language, which was no
- Published
- 2019
- Full Text
- View/download PDF
12. Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction
- Author
-
Kauw, F., Bennink, E., de Jong, H., Kappelle, L.J. (Jaap), Horsch, AD, Velthuis, B.K. (Birgitta), Dankbaar, JW, Majoie, C.B. (Charles), Roos, YB, Duijm, LE, Keizer, K, Lugt, A. (Aad) van der, Dippel, D.W.J. (Diederik), de Greve, K.E., Bienfait, H.P. (Henri), van Walderveen, MA, Wermer, M.J., Nijeholt, G., Boiten, J., Duyndam, D., Kwa, V.I., Meijer, F.J., Dijk, E.J. (Ewoud) van, Kesselring, FO, Hofmeijer, J., Vos, J.A., Schonewille, WJ, Rooij, W.J. (W.) van, de Kort, PL, Pleiter, CC, Bakker, S.L., Bot, J.J. (Jan), Visser, M.C. (Marieke), Schaaf, I.C. (Irene) van der, Mali, W.P. (Willem), van Seeters, T, Niesten, JM, Biessels, GJ, Luitse, MJ, Graaf, Y. (Yolanda) van der, Kauw, F., Bennink, E., de Jong, H., Kappelle, L.J. (Jaap), Horsch, AD, Velthuis, B.K. (Birgitta), Dankbaar, JW, Majoie, C.B. (Charles), Roos, YB, Duijm, LE, Keizer, K, Lugt, A. (Aad) van der, Dippel, D.W.J. (Diederik), de Greve, K.E., Bienfait, H.P. (Henri), van Walderveen, MA, Wermer, M.J., Nijeholt, G., Boiten, J., Duyndam, D., Kwa, V.I., Meijer, F.J., Dijk, E.J. (Ewoud) van, Kesselring, FO, Hofmeijer, J., Vos, J.A., Schonewille, WJ, Rooij, W.J. (W.) van, de Kort, PL, Pleiter, CC, Bakker, S.L., Bot, J.J. (Jan), Visser, M.C. (Marieke), Schaaf, I.C. (Irene) van der, Mali, W.P. (Willem), van Seeters, T, Niesten, JM, Biessels, GJ, Luitse, MJ, and Graaf, Y. (Yolanda) van der
- Abstract
Background and Purpose— Predicting malignant middle cerebral artery (MCA) infarction can help to identify patients who may benefit from preventive decompressive surgery. We aimed to investigate the association between the ratio of intracranial cerebrospinal fluid (CSF) volume to intracranial volume (ICV) and malignant MCA infarction. Methods— Patients with an occlusion proximal to the M3 segment of the MCA were selected from the DUST (Dutch Acute Stroke Study). Admission imaging included noncontrast computed tomography (CT), CT perfusion, and CT angiography. Patient characteristics and CT findings were collected. The ratio of intracranial CSF volume to ICV (CSF/ICV) was quantified on admission thin-slice noncontrast CT. Malignant MCA infarction was defined as a midline shift of >5 mm on follow-up noncontrast CT, which was performed 3 days after the stroke or in case of clinical deterioration. To test the association between CSF/ICV and malignant MCA infarction, odds ratios and 95% CIs were calculated for 3 multivariable models by using binary logistic regression. Model performances were compared by using the likelihood ratio test. Results— Of the 286 included patients, 35 (12%) developed malignant MCA infarction. CSF/ICV was independently associated with malignant MCA infarction in 3 multivariable models: (1) with age and admission National Institutes of Health Stroke Scale (odds ratio, 3.3; 95% CI, 1.1–11.1), (2) with admission National Institutes of Health Stroke Scale and poor collateral score (odds ratio, 7.0; 95% CI, 2.6–21.3), and (3) with terminal internal carotid artery or proximal M1 occlusion and poor collateral score (odds ratio, 7.7; 95% CI, 2.8–23.9). The performance of model 1 (areas under the receiver operating characteristic curves, 0.795 versus 0.824; P=0.033), model 2 (areas under the receiver operating characteristic curves, 0.813 versus 0.850; P<0.001), and model 3 (areas under the receiver operating characteristic curves, 0.811 versus 0.856; P<0
- Published
- 2019
- Full Text
- View/download PDF
13. Cortical Microinfarcts and White Matter Connectivity in Memory Clinic Patients
- Author
-
Brain, Opleiding Neurologie, Zorglijn AN/AAN Medisch, Beeldverwerking ISI, Circulatory Health, Ferro, DA, Heinen, R, de Brito Robalo, BM, Kuijf, HJ, Biessels, GJ, Reijmer, YD, Utrecht Vascular Cognitive Impairment (VCI) Study group, Brain, Opleiding Neurologie, Zorglijn AN/AAN Medisch, Beeldverwerking ISI, Circulatory Health, Ferro, DA, Heinen, R, de Brito Robalo, BM, Kuijf, HJ, Biessels, GJ, Reijmer, YD, and Utrecht Vascular Cognitive Impairment (VCI) Study group
- Published
- 2019
14. The Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping: Design and multicenter pilot study
- Author
-
Weaver, NA, Zhao, L, Biesbroek, JM, Kuijf, HJ, Aben, HP, Bae, H J, Giessen, Ruben, Hilal, Saima, vom Hofe, Elise, Koudstaal, Peter, Xin, X, Biessels, GJ, Weaver, NA, Zhao, L, Biesbroek, JM, Kuijf, HJ, Aben, HP, Bae, H J, Giessen, Ruben, Hilal, Saima, vom Hofe, Elise, Koudstaal, Peter, Xin, X, and Biessels, GJ
- Published
- 2019
15. Nonfocal transient neurological attacks are related to cognitive impairment in patients with heart failure
- Author
-
Oudeman, EA, Greving, JP, Hooghiemstra, AM, Brunner-La Rocca, HP, Biessels, GJ, Kappelle, LJ, Daemen, MJ, van Buchem, MA, van der Geest, RJ, van Osch, MJP, de Roos, A, van der Flier, WM, van Rossum, AC, la Rocca, HPB, Ikram, Arfan, Koudstaal, Peter, Niessen, Wiro, van Oostenbrugge, R, Bots, ML, Oudeman, EA, Greving, JP, Hooghiemstra, AM, Brunner-La Rocca, HP, Biessels, GJ, Kappelle, LJ, Daemen, MJ, van Buchem, MA, van der Geest, RJ, van Osch, MJP, de Roos, A, van der Flier, WM, van Rossum, AC, la Rocca, HPB, Ikram, Arfan, Koudstaal, Peter, Niessen, Wiro, van Oostenbrugge, R, and Bots, ML
- Published
- 2019
16. Cerebral Perfusion and the Occurrence of Nonfocal Transient Neurological Attacks
- Author
-
Oudeman, EA, Bron, Esther, van den Berg-Vos, RM, Greving, JP, Biessels, GJ, Klijn, CJM, Kappelle, LJ, Oudeman, EA, Bron, Esther, van den Berg-Vos, RM, Greving, JP, Biessels, GJ, Klijn, CJM, and Kappelle, LJ
- Published
- 2019
17. Intracranial Cerebrospinal Fluid Volume as a Predictor of Malignant Middle Cerebral Artery Infarction
- Author
-
Kauw, F, Bennink, E, Jong, H, Kappelle, LJ, Horsch, AD, Velthuis, BK, Dankbaar, JW, Majoie, CB, Roos, YB, Duijm, LE, Keizer, K, van der Lugt, Aad, Dippel, Diederik, Greve, KE, Bienfait, HP, van Walderveen, MA, Wermer, MJ, Nijeholt, G, Boiten, J, Duyndam, D, Kwa, VI, Meijer, FJ, van Dijk, EJ, Kesselring, FO, Hofmeijer, J, Vos, JA, Schonewille, WJ, van Rooij, WJ, de Kort, PL, Pleiter, CC, Bakker, SL, Bot, J, Visser, MC, van der Schaaf, IC, Mali, WP, van Seeters, T, Niesten, JM, Biessels, GJ, Luitse, MJ, Graaf, Y, Kauw, F, Bennink, E, Jong, H, Kappelle, LJ, Horsch, AD, Velthuis, BK, Dankbaar, JW, Majoie, CB, Roos, YB, Duijm, LE, Keizer, K, van der Lugt, Aad, Dippel, Diederik, Greve, KE, Bienfait, HP, van Walderveen, MA, Wermer, MJ, Nijeholt, G, Boiten, J, Duyndam, D, Kwa, VI, Meijer, FJ, van Dijk, EJ, Kesselring, FO, Hofmeijer, J, Vos, JA, Schonewille, WJ, van Rooij, WJ, de Kort, PL, Pleiter, CC, Bakker, SL, Bot, J, Visser, MC, van der Schaaf, IC, Mali, WP, van Seeters, T, Niesten, JM, Biessels, GJ, Luitse, MJ, and Graaf, Y
- Published
- 2019
18. Risico's van vitamine K-antagonisten bij cerebrale microbloedingen = Risk of vitamin K antagonists in cases of cerebral microbleeds
- Author
-
Verhaar, BJH (Barbara), Vernooij, Meike, Biessels, GJ, Muller, M, and Radiology & Nuclear Medicine
- Published
- 2018
19. Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease
- Author
-
Geijselaers, SLC, Aalten, P, Ramakers, I, de Deyn, PP, Heijboer, AC, Koek, HL, OldeRikkert, MGM, Papma, Janne, Reesink, FE, Smits, LL, Stehouwer, CDA, Teunissen, CE, Verhey, FRJ, van der Flier, WM, Biessels, GJ, Geijselaers, SLC, Aalten, P, Ramakers, I, de Deyn, PP, Heijboer, AC, Koek, HL, OldeRikkert, MGM, Papma, Janne, Reesink, FE, Smits, LL, Stehouwer, CDA, Teunissen, CE, Verhey, FRJ, van der Flier, WM, and Biessels, GJ
- Published
- 2018
20. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research
- Author
-
Dichgans, M, Wardlaw, J, Smith, E, Zietemann, V, Seshadri, S, Sachdev, P, Biessels, GJ, Fazekas, F, Benavente, O, Pantoni, L, van der Leeuw, F, Norrving, B, Matthews, P, Chen, C (Christopher Li Hsian), Mok, V, During, M, Whiteley, W, Shuler, K, Alonso, A, Black, SE, Brayne, C, Chabriat, H, Cordonnier, C, Doubal, F, Duzel, E, Ewers, M, Frayne, R, Hachinski, V, Ikram, Arfan, Jessen, F, Jouvent, E, Linn, J, O'Brien, J, van Oostenbrugge, R, Malik, R, Mazoyer, B, Schmidt, R, Sposato, LA, Stephan, B, Swartz, RH, Vernooij, Meike, Viswanathan, A, Werring, D, Abe, K, Allan, L, Arba, F, Bae, H J, Bath, P M W, Bordet, R, Breteler, M, Choi, S, Deary, I, DeCarli, C, Ebmeier, K, Feng, L, Greenberg, SM, Ihara, M, Kalaria, R, Kim, S, Lim, J S, Lindley, RI, Mead, G, Murray, A, Quinn, T, Ritchie, C, Sacco, R, Salman, RA, Sprigg, N, Sudlow, C, Thomas, A, van Boxtel, M, van der Grond, J, van der Lugt, Aad, Yang, Y H, MUMC+: MA Neurologie (3), Klinische Neurowetenschappen, Section Neuropsychology, Psychiatrie & Neuropsychologie, RS: FPN NPPP I, Epidemiology, Neurology, and Radiology & Nuclear Medicine
- Subjects
Male ,LACUNAR STROKE ,Clinical Neurology ,SMALL-VESSEL DISEASE ,METACOHORTS Consortium. Electronic address: joanna.wardlaw@ed.ac.uk ,Cohort Studies ,Risk Factors ,Surveys and Questionnaires ,WHITE-MATTER HYPERINTENSITIES ,Prevalence ,Humans ,Cognitive Dysfunction ,Neurodegeneration ,METACOHORTS Consortium ,Cerebrovascular disease ,Survey ,Aged ,Science & Technology ,Dementia, Vascular ,Incidence ,STROKE SURVIVORS ,Neurodegenerative Diseases ,1103 Clinical Sciences ,IMPAIRMENT ,Neurodegeneration, Cohorts, Survey ,Small vessel disease ,ALZHEIMERS-DISEASE ,Cerebrovascular Disorders ,GAIT DISORDERS ,Geriatrics ,Female ,Dementia ,Neurosciences & Neurology ,STRUCTURAL NETWORK EFFICIENCY ,1109 Neurosciences ,Life Sciences & Biomedicine ,PARKINSONIAN SIGNS ,Cohorts - Abstract
Dementia is a global problem and major target for health care providers. Although up to 45% of cases are primarily or partly due to cerebrovascular disease, little is known of these mechanisms or treatments because most dementia research still focuses on pure Alzheimer's disease. An improved understanding of the vascular contributions to neurodegeneration and dementia, particularly by small vessel disease, is hampered by imprecise data, including the incidence and prevalence of symptomatic and clinically “silent” cerebrovascular disease, long-term outcomes (cognitive, stroke, or functional), and risk factors. New large collaborative studies with long follow-up are expensive and time consuming, yet substantial data to advance the field are available. In an initiative funded by the Joint Programme for Neurodegenerative Disease Research, 55 international experts surveyed and assessed available data, starting with European cohorts, to promote data sharing to advance understanding of how vascular disease affects brain structure and function, optimize methods for cerebrovascular disease in neurodegeneration research, and focus future research on gaps in knowledge. Here, we summarize the results and recommendations from this initiative. We identified data from over 90 studies, including over 660,000 participants, many being additional to neurodegeneration data initiatives. The enthusiastic response means that cohorts from North America, Australasia, and the Asia Pacific Region are included, creating a truly global, collaborative, data sharing platform, linked to major national dementia initiatives. Furthermore, the revised World Health Organization International Classification of Diseases version 11 should facilitate recognition of vascular-related brain damage by creating one category for all cerebrovascular disease presentations and thus accelerate identification of targets for dementia prevention.
- Published
- 2016
21. Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment
- Author
-
Leeuwis, AE, Hooghiemstra, AM, Amier, R, Ferro, DA, Franken, L, Nijveldt, R, Kuijer, JPA, Bronzwaer, A-SGT, van Lieshout, JJ, Rietberg, MB, Veerbeek, JM, Huijsmans, RJ, Backx, FJG, Teunissen, CE, Bron, Esther, Barkhof, F, Prins, ND, Shahzad, R, Niessen, Wiro, de Roos, A, van Osch, MJP, van Rossum, AC, Biessels, GJ, van der Flier, WM, Heart Brain Connection study, g, Leeuwis, AE, Hooghiemstra, AM, Amier, R, Ferro, DA, Franken, L, Nijveldt, R, Kuijer, JPA, Bronzwaer, A-SGT, van Lieshout, JJ, Rietberg, MB, Veerbeek, JM, Huijsmans, RJ, Backx, FJG, Teunissen, CE, Bron, Esther, Barkhof, F, Prins, ND, Shahzad, R, Niessen, Wiro, de Roos, A, van Osch, MJP, van Rossum, AC, Biessels, GJ, van der Flier, WM, and Heart Brain Connection study, g
- Published
- 2017
22. The Missing Link in the Pathophysiology of Vascular Cognitive Impairment: Design of the Heart-Brain Study
- Author
-
Hooghiemstra, AM, Bertens, AS, Leeuwis, AE, Bron, Esther, Bots, ML, Brunner-La Rocca, HP, de Craen, AJM, van der Geest, RJ, Greving, JP, Kappelle, LJ, Niessen, Wiro, van Oostenbrugge, RJ, van Osch, MJP, de Roos, A, van Rossum, AC, Biessels, GJ, van Buchem, MA, Daemen, M, van der Flier, WM, Hooghiemstra, AM, Bertens, AS, Leeuwis, AE, Bron, Esther, Bots, ML, Brunner-La Rocca, HP, de Craen, AJM, van der Geest, RJ, Greving, JP, Kappelle, LJ, Niessen, Wiro, van Oostenbrugge, RJ, van Osch, MJP, de Roos, A, van Rossum, AC, Biessels, GJ, van Buchem, MA, Daemen, M, and van der Flier, WM
- Published
- 2017
23. Neuropsychological assessment in vascular cognitive impairment: a call to lay the quest for the best test to rest
- Author
-
Biessels, Geert Jan and Biessels, GJ
- Abstract
NA
- Published
- 2024
- Full Text
- View/download PDF
24. Diagnosis and treatment of vascular damage in dementia
- Author
-
Biessels, GJ and Biessels, GJ
- Published
- 2016
25. Diagnosis and treatment of vascular damage in dementia
- Author
-
ZL Algemene Neurologie Medisch, Circulatory Health, Brain, Biessels, GJ, ZL Algemene Neurologie Medisch, Circulatory Health, Brain, and Biessels, GJ
- Published
- 2016
26. CT angiography and CT perfusion improve prediction of infarct volume in patients with anterior circulation stroke
- Author
-
van Seeters, T, Biessels, GJ, Kappelle, LJ, van der Schaaf, IC, Dankbaar, JW, Horsch, AD, Niesten, JM, Luitse, MJA, Majoie, CBLM, Vos, JA, Schonewille, WJ, Walderveen, MAA, Wermer, MJH, Duijm, LEM, Keizer, K, Bot, JCJ, Visser, MC, van der Lugt, Aad, Dippel, Diederik, Kesselring, Fohw, Hofmeijer, J, Nijeholt, GJLA, Boiten, J, van Rooij, WJ, de Kort, PLM, Roos, YBWEM, Meijer, F J A, Pleiter, CC, Mali, WPTM, van der Graaf, Y, Velthuis, BK, van Seeters, T, Biessels, GJ, Kappelle, LJ, van der Schaaf, IC, Dankbaar, JW, Horsch, AD, Niesten, JM, Luitse, MJA, Majoie, CBLM, Vos, JA, Schonewille, WJ, Walderveen, MAA, Wermer, MJH, Duijm, LEM, Keizer, K, Bot, JCJ, Visser, MC, van der Lugt, Aad, Dippel, Diederik, Kesselring, Fohw, Hofmeijer, J, Nijeholt, GJLA, Boiten, J, van Rooij, WJ, de Kort, PLM, Roos, YBWEM, Meijer, F J A, Pleiter, CC, Mali, WPTM, van der Graaf, Y, and Velthuis, BK
- Published
- 2016
27. FLAIR images at 7 Tesla MRI highlight the ependyma and the outer layers of the cerebral cortex
- Author
-
van Veluw, S.J., Fracasso, Alessio, Visser, Fredy, Spliet, W.G., Luijten, Peter, Biessels, GJ, Zwanenburg, Jaco, Leerstoel Verstraten, Afd Psychologische functieleer, Experimental Psychology (onderzoeksprogramma PF), and Helmholtz Institute
- Subjects
Ultra-high field MRI ,Cortical layers ,Ependyma ,FLAIR ,Image contrast ,Layer I - Abstract
Objectives: Fluid-attenuated inversion recovery (FLAIR) imaging is an important clinical ‘work horse’ for brain MRI and has proven to facilitate imaging of both intracortical lesions as well as cortical layers at 7 T MRI. A prominent observation on 7 T FLAIR images is a hyperintense rim at the cortical surface and around the ventricles.We aimed to clarify the anatomical correlates and underlying contrast mechanisms of this hyperintense rim. Materials and Methods: Two experiments with post-mortem human brain tissue were performed. FLAIR and T2-weighted imageswere obtained at typical in vivo (0.8mmisotropic) and high resolution (0.25mmisotropic). At one location the cortical surfacewas partly removed, and scanned again. Imagingwas followed by histological and immunohistochemical analysis. Additionally, several simulations were performed to evaluate the potential contribution from an artifact due to water diffusion. Results: The hyperintense rim corresponded to the outer – glia rich – layer of the cortex and disappeared upon removal of that layer. At the ventricles, the rim corresponded to the ependymal layer, and was not present at white matter/fluid borders at an artificial cut. The simulations supported the hypothesis that the hyperintense rim reflects the tissue properties in the outer cortical layers (or ependymal layer for the ventricles), and is not merely an artifact, although not all observations were explained by the simulated model of the contrast mechanism. Conclusions: 7 T FLAIR seems to amplify the signal from layers I–III of the cortex and the ependyma around the ventricles. Although diffusion of water from layer I into CSF does contribute to this effect, a long T2 relaxation time constant in layer I, and probably also layer II–III, is most likely themajor contributor, since the rimdisappears upon removal of that layer. This knowledge can help the interpretation of imaging results in cortical development and in patients with cortical pathology.
- Published
- 2014
28. MRBrainS Challenge: Online Evaluation Framework for Brain Image Segmentation in 3T MRI Scans
- Author
-
Mendrik, AM, Vincken, KL, Kuijf, HJ, Breeuwer, M, Bouvy, W, de Bresser, J, Alansary, A, de Bruijne, M, Caras, A, El-Baz, A, Jogh, A, Katyal, AR, Khan, AR, van der Lijn, F, Mahmood, Q, Mukherjee, R, van Opbroek, A, Paneri, S, Pereira, S, Persson, M, Rajch, M, Sarikaya, D, Smedby, Örjan, Silval, CA, Vrooman, HA, Vyas, S, Wang, Chunliang, Zhao, L, Biessels, GJ, Viergever, MA, Mendrik, AM, Vincken, KL, Kuijf, HJ, Breeuwer, M, Bouvy, W, de Bresser, J, Alansary, A, de Bruijne, M, Caras, A, El-Baz, A, Jogh, A, Katyal, AR, Khan, AR, van der Lijn, F, Mahmood, Q, Mukherjee, R, van Opbroek, A, Paneri, S, Pereira, S, Persson, M, Rajch, M, Sarikaya, D, Smedby, Örjan, Silval, CA, Vrooman, HA, Vyas, S, Wang, Chunliang, Zhao, L, Biessels, GJ, and Viergever, MA
- Abstract
Many methods have been proposed for tissue segmentation in brain MRI scans. The multitude of methods proposed complicates the choice of one method above others. We have therefore established the MRBrainS online evaluation framework for evaluating (semi)automatic algorithms that segment gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) on 3T brain MRI scans of elderly subjects (65–80 y). Participants apply their algorithms to the provided data, after which their results are evaluated and ranked. Full manual segmentations of GM, WM, and CSF are available for all scans and used as the reference standard. Five datasets are provided for training and fifteen for testing. The evaluated methods are ranked based on their overall performance to segment GM, WM, and CSF and evaluated using three evaluation metrics (Dice, H95, and AVD) and the results are published on the MRBrainS13 website. We present the results of eleven segmentation algorithms that participated in the MRBrainS13 challenge workshop at MICCAI, where the framework was launched, and three commonly used freeware packages: FreeSurfer, FSL, and SPM. The MRBrainS evaluation framework provides an objective and direct comparison of all evaluated algorithms and can aid in selecting the best performing method for the segmentation goal at hand., QC 20160112. QC 20160113
- Published
- 2015
- Full Text
- View/download PDF
29. Multifocal motor neuropathy
- Author
-
Venables Gs, Franssen H, Gibson A, van den Berg Lh, L.J. Kappelle, J. H. J. Wokke, and Biessels Gj
- Subjects
medicine.medical_specialty ,Pathology ,Weakness ,Neurology ,Biopsy ,Neural Conduction ,Mismatch negativity ,Chronic inflammatory demyelinating polyneuropathy ,Neurological disorder ,behavioral disciplines and activities ,Diagnosis, Differential ,Fasciculation ,medicine ,Humans ,Motor Neuron Disease ,Clinical Laboratory Techniques ,business.industry ,medicine.disease ,Combined Modality Therapy ,Peripheral neuropathy ,Chronic Disease ,Immunology ,Neurology (clinical) ,medicine.symptom ,business ,psychological phenomena and processes ,Demyelinating Diseases ,Multifocal motor neuropathy - Abstract
We present a review of the literature on multifocal motor neuropathy (MMN), a rare neurological disorder which has features in common with both chronic inflammatory demyelinating neuropathy and lower motor neuron disease. Clinically, MMN is characterised by slowly progressive asymmetrical limb weakness, usually most prominent in the forearms. Weakness may be associated with muscle wasting, fasciculations and decreased tendon reflexes. Serum anti-GM1 ganglioside antibody titres may be increased. The diagnostic hallmark of MMN is the electrophysiological demonstration of persistent localised motor conduction blocks, with otherwise normal or near-normal motor and sensory conduction velocities. The pathogenesis of MMN has not been elucidated completely. There is, however, substantial evidence for an autoimmune mechanism. Based on the possible involvement of the immune system in the pathogenesis of MMN the therapeutic efficacy of several immunomodulatory drugs has been tested. Treatment of MMN patients with human immunoglobulin or cyclophosphamide is usually followed by a marked improvement of strength. The finding that MMN is a potentially treatable disorder underscores the importance of distinguishing MMN from lower motor neuron disease, for which no effective therapy is currently available.
- Published
- 1997
30. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)
- Author
-
Biessels, GJ, Bril, V, Calcutt, NA, Cameron, NE, Cotter, MA, Dobrowsky, R, Feldman, EL, Fernyhough, P, Jakobsen, J, Malik, RA, Mizisin, AP, Oates, PJ, Obrosova, IG, Pop-Busui, R, Russell, JW, Sima, AA, Stevens, MJ, Schmidt, RE, Tesfaye, S, Veves, A, Vinik, AI, Wright, DE, Yagihashi, S, Yorek, MA, Ziegler, D, and Zochodne, DW
- Subjects
Behavior ,peripheral neuropathy ,Neurology & Neurosurgery ,Biomedical Research ,Consensus ,diabetes ,Behavior, Animal ,Animal ,Pain Research ,Neurosciences ,Neural Conduction ,Neurodegenerative ,diabetic neuropathy ,Article ,Disease Models, Animal ,Good Health and Well Being ,Phenotype ,Diabetic Neuropathies ,Disease Models ,Animals ,Humans ,neuropathy ,Peripheral Nerves ,Chronic Pain ,Metabolic and endocrine - Abstract
NIDDK, JDRF, and the Diabetic Neuropathy Study Group of EASD sponsored a meeting to explore the current status of animal models of diabetic peripheral neuropathy. The goal of the workshop was to develop a set of consensus criteria for the phenotyping of rodent models of diabetic neuropathy. The discussion was divided into five areas: (1) status of commonly used rodent models of diabetes, (2) nerve structure, (3) electrophysiological assessments of nerve function, (4) behavioral assessments of nerve function, and (5) the role of biomarkers in disease phenotyping. Participants discussed the current understanding of each area, gold standards (if applicable) for assessments of function, improvements of existing techniques, and utility of known and exploratory biomarkers. The research opportunities in each area were outlined, providing a possible roadmap for future studies. The meeting concluded with a discussion on the merits and limitations of a unified approach to phenotyping rodent models of diabetic neuropathy and a consensus formed on the definition of the minimum criteria required for establishing the presence of the disease. A neuropathy phenotype in rodents was defined as the presence of statistically different values between diabetic and control animals in 2 of 3 assessments (nocifensive behavior, nerve conduction velocities, or nerve structure). The participants propose that this framework would allow different research groups to compare and share data, with an emphasis on data targeted toward the therapeutic efficacy of drug interventions.
- Published
- 2013
31. FLAIR images at 7 Tesla MRI highlight the ependyma and the outer layers of the cerebral cortex.
- Author
-
Leerstoel Verstraten, Afd Psychologische functieleer, Experimental Psychology (onderzoeksprogramma PF), Helmholtz Institute, van Veluw, S.J., Fracasso, Alessio, Visser, Fredy, Spliet, W.G., Luijten, Peter, Biessels, GJ, Zwanenburg, Jaco, Leerstoel Verstraten, Afd Psychologische functieleer, Experimental Psychology (onderzoeksprogramma PF), Helmholtz Institute, van Veluw, S.J., Fracasso, Alessio, Visser, Fredy, Spliet, W.G., Luijten, Peter, Biessels, GJ, and Zwanenburg, Jaco
- Published
- 2014
32. The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results
- Author
-
Aalten, P, Ramakers, IHGB, Biessels, GJ, de Deyn, PP, Koek, HL, OldeRikkert, MGM, Oleksik, AM, Richard, E, Smits, LL, van Swieten, J.C., Teune, LK, van der Lugt, Aad, Barkhof, F, Teunissen, CE, Rozendaal, N, Verhey, FRJ, van der Flier, WM, Aalten, P, Ramakers, IHGB, Biessels, GJ, de Deyn, PP, Koek, HL, OldeRikkert, MGM, Oleksik, AM, Richard, E, Smits, LL, van Swieten, J.C., Teune, LK, van der Lugt, Aad, Barkhof, F, Teunissen, CE, Rozendaal, N, Verhey, FRJ, and van der Flier, WM
- Abstract
Background: The Parelsnoer Institute is a collaboration between 8 Dutch University Medical Centers in which clinical data and biomaterials from patients suffering from chronic diseases (so called "Pearls") are collected according to harmonized protocols. The Pearl Neurodegenerative Diseases focuses on the role of biomarkers in the early diagnosis, differential diagnosis and in monitoring the course of neurodegenerative diseases, in particular Alzheimer's disease. The objective of this paper is to describe the design and methods of the Pearl Neurodegenerative Diseases, as well as baseline descriptive variables, including their biomarker profile. Methods: The Pearl Neurodegenerative Diseases is a 3-year follow-up study of patients referred to a memory clinic with cognitive complaints. At baseline, all patients are subjected to a standardized examination, including clinical data and biobank materials, e.g. blood samples, MRI and cerebrospinal fluid. At present, in total more than 1000 patients have been included, of which cerebrospinal fluid and DNA samples are available of 211 and 661 patients, respectively. First descriptives of a subsample of the data (n = 665) shows that patients are diagnosed with dementia (45%), mild cognitive impairment (31%), and subjective memory complaints (24%). Discussion: The Pearl Neurodegenerative Diseases is an ongoing large network collecting clinical data and biomaterials of more than 1000 patients with cognitive impairments. The project has started with data analyses of the baseline characteristics and biomarkers, which will be the starting point of future specific research questions that can be answered by this unique dataset.
- Published
- 2014
33. Prediction of outcome in patients with suspected acute ischaemic stroke with CT perfusion and CT angiography: the Dutch acute stroke trial (DUST) study protocol
- Author
-
van Seeters, T, Biessels, GJ, van der Schaaf, IC, Dankbaar, JW, Horsch, AD, Luitse, MJA, Niesten, JM, Mali, WPTM, Kappelle, LJ, van der Graaf, Y (Yolanda), Velthuis, BK, van Seeters, T, Biessels, GJ, van der Schaaf, IC, Dankbaar, JW, Horsch, AD, Luitse, MJA, Niesten, JM, Mali, WPTM, Kappelle, LJ, van der Graaf, Y (Yolanda), and Velthuis, BK
- Abstract
Background: Prediction of clinical outcome in the acute stage of ischaemic stroke can be difficult when based on patient characteristics, clinical findings and on non-contrast CT. CT perfusion and CT angiography may provide additional prognostic information and guide treatment in the early stage. We present the study protocol of the Dutch acute Stroke Trial (DUST). The DUST aims to assess the prognostic value of CT perfusion and CT angiography in predicting stroke outcome, in addition to patient characteristics and non-contrast CT. For this purpose, individualised prediction models for clinical outcome after stroke based on the best predictors from patient characteristics and CT imaging will be developed and validated. Methods/design: The DUST is a prospective multi-centre cohort study in 1500 patients with suspected acute ischaemic stroke. All patients undergo non-contrast CT, CT perfusion and CT angiography within 9 hours after onset of the neurological deficits, and, if possible, follow-up imaging after 3 days. The primary outcome is a dichotomised score on the modified Rankin Scale, assessed at 90 days. A score of 0-2 represents good outcome, and a score of 3-6 represents poor outcome. Three logistic regression models will be developed, including patient characteristics and non-contrast CT (model A), with addition of CT angiography (model B), and CT perfusion parameters (model C). Model derivation will be performed in 60% of the study population, and model validation in the remaining 40% of the patients. Additional prognostic value of the models will be determined with the area under the curve (AUC) from the receiver operating characteristic (ROC) curve, calibration plots, assessment of goodness-of-fit, and likelihood ratio tests. Discussion: This study will provide insight in the added prognostic value of CTP and CTA parameters in outcome prediction of acute stroke patients. The prediction models that will be developed in this study may help guide future treatm
- Published
- 2014
34. Fourth European stroke science workshop
- Author
-
Debette, S, Strbian, D, Wardlaw, JM, van der Worp, HB, Rinkel, GJE, Caso, V, Dichgans, M, Tournier-Lasserve, E, Grefkes, C, Kelly, PJ, Muir, K, Berge, E, Trégouët, DA, Roffe, C, Brainin, M, Beck, J, Steiner, T, de Lau, LM, Jouvent, E, Veltkamp, R, Baron, JC, Nedeltchev, K, Bath, PM, Quinn, TJ, Richard, E, Ziemann, U, Liesz, A, Ntaios, G, Iadecola, C, Lees, KR, Christensen, H Krarup, van Veluw, SJ, Endres, M, Anderson, CS, Molina, CA, Düring, M, Dufouil, C, Ostergaard, L, Samani, NJ, Fischer, U, de Leeuw, FE, Norrving, B, Biessels, GJ, Cordonnier, C, Mas, JL, and Mattle, H
- Abstract
Lake Eibsee, Garmisch-Partenkirchen, 16 to 18 November, 2017: The European Stroke Organisation convened >120 stroke experts from 21 countries to discuss latest results and hot topics in clinical, translational and basic stroke research. Since its inception in 2011, the European Stroke Science Workshop has become a cornerstone of European Stroke Organisation’s academic activities and a major highlight for researchers in the field. Participants include stroke researchers at all career stages and with different backgrounds, who convene for plenary lectures and discussions. The workshop was organised in seven scientific sessions focusing on the following topics: (1) acute stroke treatment and endovascular therapy; (2) small vessel disease; (3) opportunities for stroke research in the omics era; (4) vascular cognitive impairment; (5) intracerebral and subarachnoid haemorrhage; (6) alternative treatment concepts and (7) neural circuits, recovery and rehabilitation. All sessions started with a keynote lecture providing an overview on current developments, followed by focused talks on a timely topic with the most recent findings, including unpublished data. In the following, we summarise the key contents of the meeting. The program is provided in the online only Data Supplement.The workshop started with a key note lecture on how to improve the efficiency of clinical trial endpoints in stroke, which was delivered by Craig Anderson (Sydney, Australia) and set the scene for the following discussions.
- Published
- 2018
- Full Text
- View/download PDF
35. Detection of cerebral microbleeds with dual echo T2*-weighted imaging at 7.0 Tesla MRI
- Author
-
Conijn, MMA, primary, Luijten, PR, additional, Zwanenburg, JJM, additional, Visser, F, additional, Biessels, GJ, additional, Geerlings, MI, additional, and Hendrikse, J, additional
- Published
- 2010
- Full Text
- View/download PDF
36. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study.
- Author
-
Reijmer YD, Brundel M, de Bresser J, Kappelle LJ, Leemans A, Biessels GJ, Utrecht Vascular Cognitive Impairment Study Group, Reijmer, Yael D, Brundel, Manon, de Bresser, Jeroen, Kappelle, L Jaap, Leemans, Alexander, and Biessels, Geert Jan
- Abstract
Objective: To examine whether type 2 diabetes is associated with microstructural abnormalities in specific cerebral white matter tracts and to relate these microstructural abnormalities to cognitive functioning.Research Design and Methods: Thirty-five nondemented older individuals with type 2 diabetes (mean age 71 ± 5 years) and 35 age-, sex-, and education-matched control subjects underwent a 3 Tesla diffusion-weighted MRI scan and a detailed cognitive assessment. Tractography was performed to reconstruct several white matter tracts. Diffusion tensor imaging measures, including fractional anisotropy (FA) and mean diffusivity (MD), were compared between groups and related to cognitive performance.Results: MD was significantly increased in all tracts in both hemispheres in patients compared with control subjects (P < 0.05), reflecting microstructural white matter abnormalities in the diabetes group. Increased MD was associated with slowing of information-processing speed and worse memory performance in the diabetes but not in the control group after adjustment for age, sex, and estimated IQ (group × MD interaction, all P < 0.05). These associations were independent of total white matter hyperintensity load and presence of cerebral infarcts.Conclusions: Individuals with type 2 diabetes showed microstructural abnormalities in various white matter pathways. These abnormalities were related to worse cognitive functioning. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
37. High Prevalence of Cerebral Microbleeds at 7Tesla MRI in Patients with Early Alzheimer's Disease.
- Author
-
Brundel M, Heringa SM, de Bresser J, Koek HL, Zwanenburg JJ, Jaap Kappelle L, Luijten PR, and Biessels GJ
- Published
- 2012
- Full Text
- View/download PDF
38. Heart failure and cognitive function in the general population: the Hoorn Study.
- Author
-
van den Hurk K, Reijmer YD, van den Berg E, Alssema M, Nijpels G, Kostense PJ, Stehouwer CD, Paulus WJ, Kamp O, Dekker JM, and Biessels GJ
- Published
- 2011
39. Intensive insulin therapy increases the risk of hypoglycemia in neurocritical care patients.
- Author
-
Tiemessen CA, Hoedemaekers CW, van Iersel FM, Rösken GH, van der Hoeven J, Biessels GJ, and Slooter AJ
- Published
- 2011
- Full Text
- View/download PDF
40. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.
- Author
-
Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman AP, Kappelle LJ, Mali WP, SMART Study Group, Tiehuis, Audrey M, van der Graaf, Yolanda, Visseren, Frank L, Vincken, Koen L, Biessels, Geert Jan, Appelman, Auke P A, Kappelle, L Jaap, and Mali, Willem P T M
- Published
- 2008
- Full Text
- View/download PDF
41. Brain imaging in patients with diabetes: a systematic review.
- Author
-
van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ, van Harten, Barbera, de Leeuw, Frank-Erik, Weinstein, Henry C, Scheltens, Philip, and Biessels, Geert Jan
- Published
- 2006
- Full Text
- View/download PDF
42. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes.
- Author
-
Manschot SM, Brands AMA, van der Grond J, Kessels RPC, Algra A, Kappelle LJ, Biessels GJ, Manschot, Sanne M, Brands, Augustina M A, van der Grond, Jeroen, Kessels, Roy P C, Algra, Ale, Kappelle, L Jaap, Biessels, Geert Jan, and Utrecht Diabetic Encephalopathy Study Group
- Abstract
The structural correlates of impaired cognition in type 2 diabetes are unclear. The present study compared cognition and brain magnetic resonance imaging (MRI) between type 2 diabetic patients and nondiabetic control subjects and assessed the relationship between cognition and MRI findings and blood pressure and metabolic control. The study included 113 patients and 51 control subjects. Brain MRI scans were rated for white matter lesions (WMLs), cortical and subcortical atrophy, and infarcts. Neuropsychological test scores were divided into five cognitive domains and expressed as standardized Z values. Type 2 diabetes was associated with deep WMLs (P = 0.02), cortical (P < 0.001) and subcortical (P < 0.05) atrophy, (silent) infarcts (P = 0.06), and impaired cognitive performance (attention and executive function, information-processing speed, and memory, all P < 0.05). Adjustment for hypertension did not affect the results. Within the type 2 diabetic group, cognitive function was inversely related with WMLs, atrophy, and the presence of infarcts (adjusted for age, sex, and estimated IQ), and there was a modest association with HbA1c and diabetes duration. This association was strongest for age, even more so than in control subjects. We conclude that cognitive impairments in patients with type 2 diabetes are not only associated with subcortical ischemic changes in the brain, but also with increased brain atrophy. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
43. Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus.
- Author
-
Biessels GJ, De Leeuw F, Lindeboom J, Barkhof F, Scheltens P, Biessels, G J, De Leeuw, F-E, Lindeboom, J, Barkhof, F, and Scheltens, P
- Abstract
Background: The risk of Alzheimer's disease (AD) is increased in type 2 diabetes (DM2). This increased risk has been attributed to vascular comorbidity, but other mechanisms, such as accelerated ageing of the brain, have also been implicated.Objective: To determine whether AD in patients with DM2 is associated with an increased occurrence of vascular lesions in the brain, by increased cerebral atrophy, or a combination of both.Methods: In total, 29 patients with AD and DM2 and 58 patients with AD and without DM2 were included in the study. Clinical characteristics were recorded, and a neuropsychological examination and magnetic resonance imaging (MRI) scan were performed. MRI scans were rated for cortical and subcortical atrophy, medial temporal lobe atrophy, white matter lesions, and infarcts.Results: The neuropsychological profiles of the two groups were identical. Patients with AD and DM2 had increased cortical atrophy on MRI (p<0.05) compared with the non-DM2 group. In addition, infarcts were more common (odds ratio 2.4; 95% CI 0.8 to 7.8), but this effect did not account for the increased atrophy. The other MR measures did not differ between the groups.Conclusion: The results suggest that non-vascular mechanisms, leading to increased cortical atrophy, are also involved in the increased risk of AD in DM2. [ABSTRACT FROM AUTHOR]- Published
- 2006
44. The effects of type 1 diabetes on cognitive performance: a meta-analysis.
- Author
-
Brands AMA, Biessels GJ, de Haan EHF, Kappelle LJ, Kessels RPC, Brands, Augustina M A, Biessels, Geert Jan, de Haan, Edward H F, Kappelle, L Jaap, and Kessels, Roy P C
- Abstract
Objective: To investigate the exact nature and magnitude of cognitive impairments in patients with type 1 diabetes and the possible association with other disease variables, such as recurrent episodes of hypoglycemia and metabolic control.Research Design and Methods: MedLine and PsycLit search engines were used to identify studies on cognitive performance in patients with type 1 diabetes. Effect sizes (Cohen's d), which are the standardized differences between the experimental and the control group, were calculated. In the meta-analysis, a combined d value was calculated, expressing the magnitude of associations across studies.Results: A total of 33 studies were identified that met the inclusion criteria. Compared with nondiabetic control subjects, the type 1 diabetic group demonstrated a significantly lowered performance on the following cognitive domains: intelligence (d = -0.7), speed of information processing (d = -0.3), psychomotor efficiency (d = -0.6), visual (d = -0.4) and sustained attention (d = -0.3), cognitive flexibility (d = -0.5), and visual perception (d = -0.4). Lowered cognitive performance in diabetic patients appeared to be associated with the presence of microvascular complications but not with the occurrence of severe hypoglycemic episodes or with poor metabolic control.Conclusions: In patients with type 1 diabetes, cognitive dysfunction is characterized by a slowing of mental speed and a diminished mental flexibility, whereas learning and memory are spared.The magnitude of the cognitive deficits is mild to moderate, but even mild forms of cognitive dysfunction might hamper everyday activities since they can be expected to present problems in more demanding situations. [ABSTRACT FROM AUTHOR]- Published
- 2005
- Full Text
- View/download PDF
45. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment.
- Author
-
Biessels, GJ, Cristino, NA, Rutten, GJ, Hamers, FPT, Erkelens, DW, and Gispen, WH
- Published
- 1999
- Full Text
- View/download PDF
46. Quantification of cerebral volumes on MRI 6 months after aneurysmal subarachnoid hemorrhage.
- Author
-
de Bresser J, Vincken KL, Kaspers AJ, Rinkel GJ, Viergever MA, Biessels GJ, de Bresser, Jeroen, Vincken, Koen L, Kaspers, Anne J, Rinkel, Gabriel J E, Viergever, Max A, and Biessels, Geert Jan
- Published
- 2012
- Full Text
- View/download PDF
47. Hypertensive cerebral hemorrhage: Imaging the leak with 7-T MRI.
- Author
-
Biessels GJ, Zwanenburg JJ, Visser F, Frijns CJ, and Luijten PR
- Published
- 2010
- Full Text
- View/download PDF
48. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis.
- Author
-
Kruyt ND, Biessels GJ, de Haan RJ, Vermeulen M, Rinkel GJ, Coert B, Roos YB, Kruyt, Nyika D, Biessels, Geert Jan, de Haan, Rob J, Vermeulen, Marinus, Rinkel, Gabriel J E, Coert, Bert, and Roos, Yvo B W E M
- Published
- 2009
- Full Text
- View/download PDF
49. Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease.
- Author
-
Stringer MS, Blair GW, Kopczak A, Kerkhofs D, Thrippleton MJ, Chappell FM, Maniega SM, Brown R, Shuler K, Hamilton I, Garcia DJ, Doubal FN, Clancy U, Sakka E, Poliakova T, Janssen E, Duering M, Ingrisch M, Staals J, Backes WH, van Oostenbrugge R, Biessels GJ, Dichgans M, and Wardlaw JM
- Abstract
Objective: Cerebral small vessel diseases (SVDs) are associated with cerebrovascular dysfunction, such as increased blood-brain barrier leakage (permeability surface area product), vascular pulsatility, and decreased cerebrovascular reactivity (CVR). No studies assessed all 3 functions concurrently. We assessed 3 key vascular functions in sporadic and genetic SVD to determine associations with SVD severity, subtype, and interrelations., Methods: In this prospective, cross-sectional, multicenter INVESTIGATE-SVDs study, we acquired brain magnetic resonance imaging in patients with sporadic SVD/cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), including structural, quantitative microstructural, permeability surface area product, blood plasma volume fraction, vascular pulsatility, and CVR (in response to CO
2 ) scans. We determined vascular function and white matter hyperintensity (WMH) associations, using covariate-adjusted linear regression; normal-appearing white matter and WMH differences, interrelationships between vascular functions, using linear mixed models; and major sources of variance using principal component analyses., Results: We recruited 77 patients (45 sporadic/32 CADASIL) at 3 sites. In adjusted analyses, patients with worse WMH had lower CVR (B = -1.78, 95% CI -3.30, -0.27) and blood plasma volume fraction (B = -0.594, 95% CI -0.987, -0.202). CVR was worse in WMH than normal-appearing white matter (eg, CVR: B = -0.048, 95% CI -0.079, -0.017). Adjusting for WMH severity, SVD subtype had minimal influence on vascular function (eg, CVR in CADASIL vs sporadic: B = 0.0169, 95% CI -0.0247, 0.0584). Different vascular function mechanisms were not generally interrelated (eg, permeability surface area product~CVR: B = -0.85, 95% CI -4.72, 3.02). Principal component analyses identified WMH volume/quantitative microstructural metrics explained most variance in CADASIL and arterial pulsatility in sporadic SVD, but similar main variance sources., Interpretation: Vascular function was worse with higher WMH, and in WMH than normal-appearing white matter. Sporadic SVD-CADASIL differences largely reflect disease severity. Limited vascular function interrelations may suggest disease stage-specific differences. ANN NEUROL 2024., (© 2024 The Author(s). Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.)- Published
- 2024
- Full Text
- View/download PDF
50. Markers of amyloid-β deposition and burden of enlarged perivascular spaces in patients with cognitive impairment and small vessel disease.
- Author
-
Costa AS, Exalto LG, van der Flier WM, Teunissen CE, Barkhof F, Kuijf HJ, and Biessels GJ
- Abstract
MRI-visible enlarged perivascular spaces (EPVS) are common in patients with cognitive impairment and possibly linked to Alzheimer's disease (AD) and cerebral amyloid angiopathy (CAA). In a study of memory clinic patients (n = 450; mean age 66.5 ± 7.45, 45.8% female), we investigated CSF amyloid-β (Aβ)
1-42 (AD biomarker) and strictly lobar microbleeds (CAA marker) in relation to centrum semiovale EPVS (CSO-EPVS). Age-controlled analyses showed that severe CSO-EPVS associated with Aβ status (odds ratio [OR] = 1.51, 95%CI = 1.02-2.24), but not strictly lobar microbleeds (OR = 1.39, 95%CI = 0.92-2.11), with no significant Aβ status and microbleeds interaction. This implies that in this setting, severe CSO-EPVS is not a specific indicator of CAA., Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.